Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,294 | 49,542 | 34,236 | 6,540 | 34,869 |
| Marketable Securities | 230,165 | 202,519 | 113,846 | 3,997 | N/A |
| TOTAL | $302,404 | $258,689 | $150,671 | $11,175 | $35,492 |
| Non-Current Assets | |||||
| PPE Net | 3,671 | 1,120 | 840 | 930 | 17 |
| Other Non-Current Assets | 2,448 | 401 | 225 | 234 | 1,766 |
| TOTAL | $6,119 | $1,521 | $1,065 | $1,164 | $1,783 |
| Total Assets | $308,523 | $260,210 | $151,736 | $12,339 | $37,275 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,415 | 7,640 | 2,427 | 2,000 | 2,063 |
| Accrued Expenses | 13,530 | 5,942 | 4,210 | 2,655 | 2,962 |
| TOTAL | $24,417 | $13,582 | $6,720 | $4,731 | $5,274 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 83 | 76 | 249 |
| Other Non-Current Liabilities | 3,086 | 0 | 0 | 0 | 0 |
| TOTAL | $3,086 | $372 | $228 | $311 | $N/A |
| Total Liabilities | $27,503 | $13,954 | $6,948 | $5,042 | $5,274 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,059 | 34,426 | 27,284 | N/A | N/A |
| Common Shares | 44 | 34 | 27 | 10 | 10 |
| Retained earnings | -325,331 | -184,602 | -110,252 | -76,543 | -50,671 |
| Other shareholders' equity | 0 | 0 | 0 | 40,000 | 40,000 |
| TOTAL | $281,020 | $246,256 | $144,788 | $7,297 | $32,001 |
| Total Liabilities And Equity | $308,523 | $260,210 | $151,736 | $12,339 | $37,275 |